MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a legal complaint from Novartis seeking to block its launch. In August, a Delaware ...

Since 2022, it has been the cause of major epidemics spreading outside endemic ... Drug May Counteract Muscle Loss and Osteoporosis After Rapid Weight Loss Feb. 10, 2025 — Rapid weight loss ...

000931.SZ Beijing Centergate Technologies (holding) Co., Ltd.